Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature

Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature

Immunotherapy with PD-1 inhibitors monotherapy or combined with chemotherapy comprises the first-line palliative treatment for patients with recurrent or metastatic head and neck squamous cell cancers (R/M HNSCC). The established survival advantage among responders is overshadowed by the high percen...

Full description

Bibliographic Details
Main Authors: Chance H. Bloomer, Elena Gavrila, Kimberly M. Burcher, John M. Kalada, Mark J. Chang, Rediet R. Gebeyehu, Elsabeth Asare, Lara M. Khoury, Rebecca Kinney, Bart Frizzell, Christopher A. Sullivan, Paul M. Bunch, Mercedes Porosnicu
Format: Article
Language:English
Published: SAGE Publishing 2023-08-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/17588359231193722

Similar Items

Similar Items